Privia Health Group, Inc. (PRVA): Revenue
$2.12B
Year ended 2025-12-31
$2.36B
Trailing 12 months to 2026-06-30
+16.1%
3-year compound annual growth
+21.0%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.12B | +22.3% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $1.74B | +4.7% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $1.66B | +22.2% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $1.36B | +40.4% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $966.22M | +18.3% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $817.08M | +3.9% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $786.36M | n/a | 2022-03-25, From 2019-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | 2025-12-31 | $2.12B | +22.3% |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | $1.46B | -2.8% |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $1.42B | +13.9% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $989.71M | +15.9% |
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $947.71M | +36.3% |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $780.99M | +16.3% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $427.54M | +40.0% |
| DocGo Inc. (DCGO) | 2025-12-31 | $322.20M | -47.7% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $260.21M | +53.2% |
Compare PRVA, PIII, LFST, INNV side by side · Screen every company in Services-Health Services ↗